Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 4.76B 702M 613M 563M 525M 994M 66.97B 1.01B 6.78B 2.63B 32.77B 2.64B 2.58B 113B P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 4.59B 677M 591M 543M 506M 959M 64.6B 979M 6.54B 2.53B 31.61B 2.54B 2.49B 109B EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day-0.73%
1 week-0.85%
Current month+6.65%
1 month-1.45%
3 months-21.80%
6 months+3.02%
Current year+3.02%
1 week 7.08
Extreme 7.08
8.56
1 month 7.08
Extreme 7.08
8.56
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.98
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
15.85
Manager TitleAgeSince
Chief Executive Officer 42 11/12/2017
Director of Finance/CFO 34 01/08/2019
Chief Operating Officer 45 25/08/2022
Director TitleAgeSince
Chairman 42 01/08/2019
Chairman 48 21/03/2019
Director/Board Member 46 21/03/2019
Date Insider Type Main position Quantity % Market Cap.
14/09/21Sell

Executive/Senior Manager

10,000 0.0025%
10/09/21Sell

Executive/Senior Manager

77,000 0.0189%
09/06/21Sell

Executive/Senior Manager

60,000 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
-0.73%-0.85%-17.46%+23.19% 705M
+1.86%+8.65%+56.45%+158.84% 1,063B
+3.57%+9.15%+68.70%+58.92% 611B
+3.99%+11.15%+37.41%+93.77% 444B
-1.20%-0.96%+26.12%+20.22% 324B
+4.94%+4.51%+39.76%+28.93% 285B
+2.42%+2.96%+30.77%+42.24% 283B
+2.47%+6.56%-24.26%-39.60% 219B
+3.55%+6.47%+28.79%+68.52% 195B
+4.21%+4.88%+17.49%+70.33% 156B
Average +1.11%+3.86%+26.38%+52.54% 358.14B
Weighted average by Cap. +0.73%+4.16%+41.93%+80.67%

Financials

2024 2025
Net sales 984M 145M 127M 116M 109M 205M 13.84B 210M 1.4B 543M 6.77B 545M 533M 23.38B 1.21B 178M 155M 143M 133M 252M 16.96B 257M 1.72B 665M 8.3B 668M 653M 28.65B
Net income 13.65M 2.01M 1.76M 1.61M 1.51M 2.85M 192M 2.91M 19.45M 7.54M 94.03M 7.56M 7.4M 324M 92.73M 13.68M 11.95M 10.97M 10.23M 19.37M 1.31B 19.77M 132M 51.2M 639M 51.38M 50.26M 2.2B
Net Debt 189M 27.9M 24.36M 22.37M 20.87M 39.5M 2.66B 40.32M 269M 104M 1.3B 105M 102M 4.49B -169M -24.91M -21.75M -19.97M -18.63M -35.27M -2.38B -36M -240M -93.2M -1.16B -93.53M -91.49M -4.01B
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
02/07/26 CN¥8.180 -0.73% 30,346,238
01/07/26 CN¥8.240 +7.43% 38,713,870
30/06/26 CN¥7.670 -2.29% 23,485,763
29/06/26 CN¥7.850 +8.58% 31,887,683
26/06/26 CN¥7.230 -6.71% 22,752,583

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300016 Stock